Acemox Tablet 250 mg

Acemox Tablet, manufactured by ACME Laboratories Ltd, contains Acetazolamide 250 mg as a carbonic anhydrase inhibitor. Primarily used for glaucoma and epilepsy, this tablet formulation effectively reduces intraocular pressure and controls neurological hyperactivity at ৳4.00 per unit.

This medication is prescribed for open-angle glaucoma, secondary glaucoma, edema, and as adjuvant epilepsy therapy. By inhibiting carbonic anhydrase, Acemox decreases aqueous humor secretion in eyes and stabilizes abnormal neuronal activity. Patients typically take 1 tablet 4 times daily, adjusted per individual needs.

Priced at ৳40.00 per strip (10 tablets), Acemox offers cost-effective management for chronic conditions. Store below 30°C, protected from light/moisture. Common side effects include drowsiness, gastrointestinal discomfort, and frequent urination. Consult physicians for pregnancy/lactation use due to limited safety data.

The dosage varies: adults start with 250 mg 6-hourly for glaucoma, while children require adjusted doses. Always combine with medical supervision to optimize therapeutic outcomes. Explore alternative carbonic anhydrase inhibitors if adverse effects persist.

Adults: Initial dose 250 mg 4 times daily. Children: ½ to 2 tablets in divided doses. For acute glaucoma: Start with 2 tablets, then 1 tablet every 6 hours. Take orally as directed, adjusting doses per clinical response.

Common side effects are headache, drowsiness, dizziness, fatigue, anorexia, polyurea, insomnia, gastrointestinal upset.

Pregnancy category C: Risk unknown. Avoid during lactation. Use only if potential benefit justifies risk.

Monitor electrolytes regularly. Long-term use may cause metabolic acidosis. Avoid hazardous activities if drowsy.

Geriatric patients may require dose reduction. Adjust dosing intervals in renal impairment. Contraindicated in hepatic failure. Pediatric dosing based on weight.